Bionoxx Inc.
PrivateLast Round
Series B
Mar 21, 2023
Total Funding Raised
$17.26M
Company Overview
Bionoxx Inc. is a biotechnology company that develops neutrophil-directed T cell modulation technology to fight cancer and immune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionoxx Inc. Comps
Public and private peers based on sector, stage, and business model.
Bionoxx Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 21, 2023 | ||||
| Series B | Apr 1, 2019 |
Bionoxx Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series B |
| ROI Investment Partners | Series B |
| Yuanta Investment | Series B |
| ID Ventures | Series B |
| Daekyo Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2024
Grew 36% QoQ, from 11 to 15 employees.
- Oct 20, 2024
Grew 27% QoQ, from 11 to 14 employees.
Bionoxx Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bionoxx Inc.'s valuation, stock price, and market status.
